Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years

Clinical trial NCT00184691 · COMPLETED

Trial details

NCT number: NCT00184691
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Foetal Growth Problem Small for Gestational Age

Start date: 1999-04-01
Primary completion: 2005-06-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.